Amicus Therapeutics Files Q1 2025 10-Q
Ticker: FOLD · Form: 10-Q · Filed: May 1, 2025 · CIK: 1178879
| Field | Detail |
|---|---|
| Company | Amicus Therapeutics, Inc. (FOLD) |
| Form Type | 10-Q |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
Related Tickers: FOLD
TL;DR
Amicus Therapeutics (FOLD) filed its Q1 2025 10-Q, showing financial updates. Check financials.
AI Summary
Amicus Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including changes in common stock, additional paid-in capital, and retained earnings. The company's principal executive offices are located at 47 Hulfish Street, Princeton, NJ 08542.
Why It Matters
This filing provides investors with an update on Amicus Therapeutics' financial health and operational status for the first quarter of 2025, crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing (10-Q) that provides standard financial disclosures and does not contain significant new risk factors.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial information is reported.)
- 2025-01-01 — Reporting Period Start Date (Indicates the start of the fiscal quarter for which financial information is reported.)
- 2024-12-31 — Prior Period End Date (Provides a comparative point for financial performance from the end of the previous fiscal year.)
Key Players & Entities
- AMICUS THERAPEUTICS, INC. (company) — Filer
- 20250331 (date) — Period of Report
- 20250501 (date) — Filed as of Date
- 47 HULFISH STREET (address) — Business Address
- PRINCETON (city) — Business Address City
- NJ (state) — Business Address State
- 08542 (zip_code) — Business Address Zip
- 001-33497 (company_id) — SEC File Number
FAQ
What is the primary purpose of this 10-Q filing?
This 10-Q filing provides the quarterly financial statements and management's discussion and analysis for Amicus Therapeutics, Inc. for the period ended March 31, 2025.
What is Amicus Therapeutics, Inc.'s business address?
Amicus Therapeutics, Inc.'s business address is 47 Hulfish Street, Princeton, NJ 08542.
What is the SEC file number for Amicus Therapeutics, Inc.?
The SEC file number for Amicus Therapeutics, Inc. is 001-33497.
What fiscal year end does Amicus Therapeutics, Inc. report?
Amicus Therapeutics, Inc. reports a fiscal year end of December 31.
What is the SIC code for Amicus Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Amicus Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 1, 2025 regarding AMICUS THERAPEUTICS, INC. (FOLD).